Prognostic value of adjuvant therapy in T4 non‐small cell lung cancer: An inverse probability of treatment weighting analysis
Background According to the current clinical guidelines, chemoradiotherapy is considered the standard treatment for locally advanced non‐small cell lung cancer (NSCLC). We analyzed the prognostic effect of adjuvant chemotherapy (ACT) in resected patients using the new eighth tumor node metastasis (T...
Main Authors: | Ya‐ting Song, Sheng‐li Yang, Zhen Fu, Xue‐han Liu, Si‐yu Yan, Zhi‐hui Wang, Ting‐ting Qin, Hong‐wei Jiang, Yang Jin, Ping Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.12960 |
Similar Items
-
Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis
by: Hong-Fei Gao, et al.
Published: (2020-12-01) -
Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study
by: Yuchao Zhang, et al.
Published: (2020-07-01) -
Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis
by: Pingting Ye, et al.
Published: (2021-05-01) -
Impact of Tumor Site and Adjuvant Radiotherapy on Survival of Patients with Adenoid Cystic Carcinoma: A SEER Database Analysis
by: Jason Tasoulas, et al.
Published: (2021-02-01) -
Development and Validation of a Prognostic Nomogram for Gastric Signet Ring Cell Carcinoma: A Multicenter Population-Based Study
by: Shuairan Zhang, et al.
Published: (2021-03-01)